Ocular Therapeutix (OCUL) Non-Current Debt (2013 - 2026)

Ocular Therapeutix's Non-Current Debt history runs 14 years deep, the most recent figure standing at $72.1 million for Q1 2026.

• In Q1 2026, Non-Current Debt rose 4.13% year-over-year to $72.1 million; the TTM figure through Mar 2026 stood at $72.1 million (up 4.13% YoY), while the FY2025 annual figure was $71.3 million, up 4.13% from the prior year.
• Non-Current Debt was $72.1 million for Q1 2026 at Ocular Therapeutix, up from $71.3 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $72.1 million in Q1 2026 to a low of $23.3 million in Q2 2023.
• Historically, Non-Current Debt has averaged $53.1 million across 5 years, with a median of $66.5 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Non-Current Debt dropped 7.26% in 2023, then soared 188.08% in 2024.
• A 5-year view of Non-Current Debt shows it stood at $25.3 million in 2022, then surged by 160.47% to $65.8 million in 2023, then gained by 4.13% to $68.5 million in 2024, then rose by 4.13% to $71.3 million in 2025, then grew by 1.02% to $72.1 million in 2026.
• The last three Non-Current Debt figures came in at $72.1 million (Q1 2026), $71.3 million (Q4 2025), and $70.6 million (Q3 2025), per Business Quant data.